GENOCEA BIOSCIENCES INC's ticker is GNCA and the CUSIP is 372427401. A total of 42 filers reported holding GENOCEA BIOSCIENCES INC in Q3 2021. The put-call ratio across all filers is 0.17 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $379,000 | -18.0% | 197,345 | 0.0% | 2.69% | +263.5% |
| Q2 2021 | $462,000 | -13.6% | 197,345 | 0.0% | 0.74% | +6.6% |
| Q1 2021 | $535,000 | +11.9% | 197,345 | 0.0% | 0.69% | +11.2% |
| Q4 2020 | $478,000 | +5.8% | 197,345 | 0.0% | 0.62% | -16.2% |
| Q3 2020 | $452,000 | -20.1% | 197,345 | -19.8% | 0.74% | +68.9% |
| Q2 2020 | $566,000 | +33.8% | 246,078 | 0.0% | 0.44% | +15.1% |
| Q1 2020 | $423,000 | -16.9% | 246,078 | 0.0% | 0.38% | +3.5% |
| Q4 2019 | $509,000 | -28.7% | 246,078 | 0.0% | 0.37% | -8.9% |
| Q3 2019 | $714,000 | -26.0% | 246,078 | 0.0% | 0.41% | -46.4% |
| Q2 2019 | $965,000 | – | 246,078 | – | 0.76% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ABG Innovation Capital Partners III GP Ltd | 375,000 | $435,000 | 25.16% |
| COMMODORE CAPITAL LP | 3,079,756 | $3,573,000 | 0.83% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,972,056 | $2,288,000 | 0.26% |
| NEA Management Company, LLC | 10,376,936 | $12,037,000 | 0.24% |
| BVF INC/IL | 4,012,404 | $4,654,000 | 0.17% |
| Avoro Capital Advisors LLC | 5,084,184 | $5,898,000 | 0.10% |
| Boxer Capital, LLC | 1,134,453 | $1,316,000 | 0.05% |
| Ikarian Capital, LLC | 196,821 | $228,000 | 0.03% |
| Empirical Asset Management, LLC | 10,000 | $12,000 | 0.01% |
| Point72 Asset Management, L.P. | 2,652,974 | $3,077,000 | 0.01% |